Get In Touch

Fibrodysplasia Ossificans Progressiva (FOP) Treatment: Introduction

  • Fibrodysplasia ossificans progressiva (FOP) is a very rare inherited connective tissue disorder characterized by the abnormal development of bone in areas of the body where bone is not normally present (heterotopic ossification), such as the ligaments, tendons, and skeletal muscles.
  • This disorder specifically causes the body's skeletal muscles and soft connective tissues to undergo a metamorphosis, essentially a transformation into bone, progressively locking joints in place and making movement difficult or impossible

Key Drivers of Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

  • The global fibrodysplasia ossificans progressiva FOP treatment market is anticipated to expand rapidly in the near few years. Introduction of novel therapies and increase in cases of FOP are likely to be major drivers of the FOP treatment market.
  • Rise in demand for FOP treatment and increase in awareness regarding FOP are also expected to drive the market during the forecast period
  • According to the Journal of Rare Disease Research and Treatment, in 2016, the prevalence of FOP varied substantially from approximately 0.65 per million in North America, 0.47 per million in Western Europe, and 0.27 per million in Latin America to 0.05 per million in Africa and nearly 0.04 per million in the Asia Pacific

Corticosteroids to be Highly Attractive Segment

  • In terms of drug class, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be classified into corticosteroids, NSAIDs, bisphosphonates, and others
  • The corticosteroids segment is expected to account for a major share of the global fibrodysplasia ossificans progressiva (FOP) treatment market by 2031, owing to a high usage of corticosteroids for the treatment of FOP that may help reduce the intense inflammation and tissue edema seen in the early stages of the disease.

Medication to be Highly Attractive Segment

  • In terms of treatment, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be classified into medication, occupational therapy, and others
  • The medication segment is projected to account for a major share of the global fibrodysplasia ossificans progressiva (FOP) treatment market by 2031, as medications help in the treatment of disease in the early stages and hence, are prescribed mostly by physicians.

Oral to be Highly Attractive Segment

  • In terms of route of administration, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be classified into oral, topical, and parenteral
  • Oral medications are mostly preferred for the treatment of FOP and hence, the segment is anticipated to hold a major share of the global fibrodysplasia ossificans progressiva (FOP) treatment market by 2031

Hospital Pharmacies to be Highly Lucrative Segment

  • Based on distribution channel, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be categorized into retail pharmacies, hospital pharmacies, online pharmacies, and others
  • The hospitals segment is anticipated to account for a major share of the market in the next few years due to a rise in the number of FOP treatment in hospitals

North America to Offer Significant Opportunities in Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

  • In terms of region, the global fibrodysplasia ossificans progressiva (FOP) treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America accounted for a significant share of the global market in 2020 owing to favorable healthcare infrastructure, high per capita income, and high rate of adoption of advanced surgeries in the region

Key Players Operating in Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market

The global fibrodysplasia ossificans progressiva (FOP) treatment market is semi-consolidated, with the presence of international and local players. Key players operating in the global fibrodysplasia ossificans progressiva (FOP) treatment market are:

  • Pfizer Inc.
  • AstraZeneca
  • DAIICHI SANKYO COMPANY, LIMITED
  • Regeneron Pharmaceuticals, Inc
  • Blueprint Medicines Corporation
  • Clementia
  • Oncodesign
  • La Jolla Pharmaceutical Company
  • Novartis AG
  • Ipsen Pharma
  • BIOCRYST PHARMACEUTICALS, INC.
  • Nobelpharma Co., Ltd

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market: Research Scope

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Drug Class

  • Corticosteroids
  • NSAIDs
  • Bisphosphonates
  • Others

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Treatment

  • Medication
  • Occupational Therapy
  • Surgery

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Route of Administration

  • Oral
  • Topical
  • Parenteral

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  •  Others

Global Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Fibrodysplasia Ossificans Progressiva Fop Treatment Market

Pre Book